Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids

NCT06047834 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Opioid Withdrawal (Disorder)

Interventions

DRUG: Standard of Care with Lofexidine
OTHER: Standard of Care without Lofexidine

Sponsor

BioCorRx Pharmaceuticals Inc

Collaborators

[object Object]